⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14190002 | 0.79 | ALDH1A1 (0.31) | — | |
| SCHEMBL2707847 | 0.78 | — | — | |
| SCHEMBL27882777 | 0.78 | — | — | |
| SCHEMBL919515 | 0.75 | ALDH1A1 (0.47) | — | |
| SCHEMBL1722804 | 0.74 | — | — | |
| SCHEMBL12922797 | 0.74 | — | — | |
| SCHEMBL117701 | 0.73 | — | — | |
| SCHEMBL1049538 | 0.73 | — | — | |
| SCHEMBL8747973 | 0.73 | ALDH1A1 (0.45) | — | |
| SCHEMBL919517 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897560-B1 | COMPOSITION COMPRISING OXALAMIDE GELATORS AND VEGETABLE OIL | RUDJER BOSKOVIC INST (HR) | 2022-06-29 | — | — | EP | disclosed |
| US-20220023179-A1 | COMPOSITION COMPRISING OXALAMIDE GELATORS AND VEGETABLE OIL | RUDJER BOSKOVIC INSTITUTE (HR) | 2022-01-27 | — | — | US | disclosed |
| US-20170073314-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2017-03-16 | — | — | US | disclosed |
| WO-2016023510-A1 | MICROMOLECULE COMPOUND, METHOD OF SYNTHESIS AND APPLICATION THEREOF | 嘉兴特科罗生物科技有限公司 | 2016-02-18 | — | — | WO | disclosed |
| US-20120009142-A1 | METHODS FOR TREATING HEPATITIS C | PTC THERAPEUTICS, INC. (US) | 2012-01-12 | — | — | US | disclosed |
| US-8013006-B2 | Methods for treating hepatitis C | PTC THERAPEUTICS, INC. (US) | 2011-09-06 | — | — | US | disclosed |
| CN-101273303-B | Positive photosensitive resin composition | ASAHI KASEI EMD CORP | 2011-07-06 | — | — | CN | disclosed |
| US-20100305100-A1 | METHODS FOR TREATING HEPATITIS C | PTC THERAPEUTICS, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| US-7772271-B2 | Methods for treating hepatitis C | PTC THERAPEUTICS, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| US-7687208-B2 | Positive photosensitive resin composition | ASAHI KASEI EMD CORPORATION (JP) | 2010-03-30 | — | — | US | disclosed |
| EP-1730120-A1 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2006-12-13 | — | — | EP | disclosed |
| EP-1656353-A1 | GABANERGIC MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005090317-A1 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2005-09-29 | — | — | WO | disclosed |
| US-20050215554-A1 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC | 2005-09-29 | — | — | US | disclosed |
| US-20050101614-A1 | For example, 7-(2,4-Dichloro-phenyl)-2-methyl-2H-pyrazolo[4,3-b]pyridine; for treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder, or pain | ROCHE PALO ALTO LLC | 2005-05-12 | — | — | US | disclosed |
| WO-2005016892-A1 | GABANERGIC MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-02-24 | — | — | WO | disclosed |
| EP-0530252-A4 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | US HEALTH (US) | 1993-09-01 | — | — | EP | disclosed |
| EP-0530252-A1 | AMINOALKYLCARBAMYL DERIVATIVES OF FORSKOLIN AS INTERMEDIATES FOR THE SYNTHESIS OF USEFUL FORSKOLIN DERIVATIVES | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE (US) | 1993-03-10 | — | — | EP | disclosed |
| EP-0127325-B1 | DISPERSING AGENT | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-02-22 | — | — | EP | disclosed |
| EP-0127325-A2 | Dispersing agent | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-12-05 | — | — | EP | disclosed |